154 related articles for article (PubMed ID: 2122537)
1. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
[TBL] [Abstract][Full Text] [Related]
2. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
[TBL] [Abstract][Full Text] [Related]
3. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
4. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III modulates the effect of thrombin on the metabolism of glycosaminoglycans in cultured endothelial cells.
Akai T; Kaji T; Hayakawa Y; Hayashi T; Sakuragawa N
Thromb Res; 1991 Jun; 62(6):707-16. PubMed ID: 1926061
[TBL] [Abstract][Full Text] [Related]
6. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated expression of heparin cofactor II inhibits thrombin-induced cellular responses in fibroblasts and vascular smooth muscle cells.
Hayakawa Y; Hirashima Y; Yamamoto H; Hayashi N; Kurimoto M; Kuwayama N; Endo S
Thromb Res; 2005; 116(4):357-63. PubMed ID: 16038721
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of thrombin and chymotrypsin by heparin-cofactor II.
Struss D; Storck J; Zimmermann RE
Thromb Res; 1992 Oct; 68(1):45-56. PubMed ID: 1333106
[TBL] [Abstract][Full Text] [Related]
9. Thrombin regulation of tissue-type plasminogen activator synthesis in cultured human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Res; 1993 Sep; 71(6):457-65. PubMed ID: 8134905
[TBL] [Abstract][Full Text] [Related]
10. Effect of 15-hydroperoxyeicosatetraenoic acid on the fibrinolytic factor release and the antithrombin binding of vascular endothelial cells.
Soeda S; Honda O; Fujii N; Shimeno H
Biol Pharm Bull; 1997 Jan; 20(1):15-9. PubMed ID: 9013799
[TBL] [Abstract][Full Text] [Related]
11. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA; Tollefsen DM
J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
[No Abstract] [Full Text] [Related]
13. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells.
Hayashi T; Kaji T; Hayakawa Y; Niiya K; Sakamoto M; Sakuragawa N
Thromb Res; 1991 Nov; 64(3):321-30. PubMed ID: 1805447
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative.
Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM
Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899
[TBL] [Abstract][Full Text] [Related]
15. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
Fukao H; Ueshima S; Tanaka N; Okada K; Matsuo O
Thromb Res Suppl; 1990; 10():11-20. PubMed ID: 2107596
[TBL] [Abstract][Full Text] [Related]
16. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
Yamagishi R; Koide T; Sakuragawa N
FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
18. Role of lysine 173 in heparin binding to heparin cofactor II.
Whinna HC; Blinder MA; Szewczyk M; Tollefsen DM; Church FC
J Biol Chem; 1991 May; 266(13):8129-35. PubMed ID: 1902471
[TBL] [Abstract][Full Text] [Related]
19. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
Simmons RB; Newton GR; Doctor VM
Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
